Podcasts about Morgans

SBS Finance Editor Ricardo Gonçalves speaks with Dianne Colledge from Morgans about the day's market action including Donald Trump's market influence, while Rhayna Bosch takes a closer look at job ad scams with ACCC Deputy Chairwoman Catriona Lowe.

US equity markets advanced, reversing earlier losses as investors digested Moody Ratings' decision after the close of trading last Friday (16 May) to downgrade the U.S.'s credit rating to Aa1 from Aaa - Dow rose +137-points or +0.32%, recovering from an earlier decline of -317-points. UnitedHealth Group Inc (up +8.21%) was the leading Dow component for a second straight session, continuing to rebound from steep losses last week that saw the stock fall over >20% and hit 5-year low last Thursday (15 May). The insurer disclosed after Friday's (16 May) close that new Chief Executive Officer (CEO) Stephen Hemsley spent US$25M to buy 86,700 shares, to bring his direct ownership to nearly 680K shares. And Chief Financial Officer (CFO) John Rex invested US$5M to buy 17,175 shares, to bring his direct ownership to a ~204K shares. JPMorgan Chase & Co (down -1.00%) after the investment bank hosted its annual investor day, reiterating its key financial guidance. JPMorgan maintained its forecast for full-year net interest income (NII) at ~US$94.5B, including US$90B excluding markets, and projected expenses to hold steady at ~US$95B. The bank also reaffirmed its 17% return on tangible common equity (ROTCE) target. Meanwhile, CEO chief Jamie Dimon warned against complacency in the face of a slew of risks, citing everything from inflation and credit spreads to geopolitics.

US equity markets advanced on Friday (16 May) to cap a strong week and despite news Moody Ratings had downgraded the US's highest investment grade position - Dow rose +332-points or +0.78% to 42,654.74, moving into positive territory for 2025. UnitedHealth Group Inc rebounded +6.40%, clawing back some of the heavy losses posted in the prior session amid reports that the insurer's Medicare Advantage business was the subject of a criminal probe. News of the investigation came on the heels of the insurance giant withdrawing its full-year guidance and announcing the departure of its CEO. Nvidia Corp added +0.42% ahead of CEO Jensen Huang taking the stage on Sunday (18 May) at Computex, an annual technology trade show, with this year's theme - “AI Next” - focused squarely on the emerging technology that has lately powered growth in the company's business. Microsoft Corp after offering a series of new concessions to the European Commission (EC) in a bid to settle a long-running antitrust investigation into the bundling of its Teams communications app with Office 365. Its proposal reportedly included unbundling Teams from its Office and Microsoft 365 software suites, offering those products at a lower price without Teams, and enhancing interoperability for rival services.

The biographer Ron Chernow has written about the Rockefellers and the Morgans. His book about George Washington won a Pulitzer Prize. His book about Alexander Hamilton was adapted into a hit Broadway musical. Now, in “Mark Twain,” Chernow turns to the life of the author and humorist who became one of the 19th century's biggest celebrities and, along the way, did much to reshape American literature in his own image.On this week's episode of the podcast, Chernow tells the host Gilbert Cruz how he came to write about Twain and what interested him most about his subject.“The thing that triggered this Mark Twain mania in me was more Mark Twain the platform artist, Mark Twain the political pundit, Mark Twain the original celebrity, even more than Mark Twain the novelist or short story writer,” Chernow says. But at the same time, “I felt that he was very seminal in terms of bringing, to American literature, really bringing the heartland alive — writing about ordinary people in the vernacular and taking this wild throbbing kind of madcap culture, of America's small towns in rural areas, and really introducing that into fiction.” Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

US equity markets advanced - Dow rose +272-points or +0.65%. Cisco Systems Inc rallied +4.85% and was the leading performer in the 30-stock index overnight after the networking company reported earnings per share (EPS) and revenue that topped consensus analysts' forecasts for the fiscal third quarter after the close of the previous session. UnitedHealth Group dropped -10.93% following a report from The Wall Street Journal (WSJ) published after the close of the previous session that said the Justice Department was investigating the insurer for possible Medicare fraud. UnitedHealth said in a statement it hadn't been notified by the Justice Department of the criminal investigation, adding that it stands “by the integrity of our Medicare Advantage program.” Apple Inc eased -0.47% after President Trump chided the company's Chief Executive Officer (CEO) Tim Cook, saying he wanted the iPhone maker to build more of its devices in the U.S. and not in India. “I had a little problem with Tim Cook yesterday. I said to him, Tim, you're my friend. I treated you very good. You're coming here with $500 billion but now here you are building all over India,” President Trump said in Qatar.

• US equity markets advanced - Dow slipped -89-points or -0.21%, with Merck & Company Inc down -4.12% was the worst performer in the 30-stock index. UnitedHealth Group Inc dropped over >7% in extended trading (after sliding -1.08% in regular trading) after the Wall Street Journal reported that the U.S. Justice Department is investigating the insurer for potential criminal fraud in its Medicare Advantage business. Nvidia Corp logged a third consecutive session of gains (up +4.16%), climbing over >15% over that stretch and seeing the chipmaker become the third member of the so-called ‘Magnificent Seven' cohort of large capitalisation stocks to move back into positive territory for the calendar year-to-date – joining fellow Dow component Microsoft Corp (+0.85%) and Meta Platforms Inc (+0.51%). Nvidia also saw its market capitalisation climb back above the US$3 trillion level for the first time since February a day earlier. Boeing Co (up +0.64%) inked a record-breaking order with Qatar Airways that will see the Middle East airline buy up to 210 jets from the US aerospace giant, marking Boeing's largest ever order of widebody aircraft. Qatar Airways also signed an agreement with GE Aerospace (+0.75%) for more than >400 engines to power the Boeing planes

US equity markets advanced as investors digested a cooler-than-expected inflation report that revived hopes of interest rate cuts later this year - Dow fell -270-points or -0.64%. UnitedHealth Group Inc slumped -17.79%, alone wiping ~410-points off the 30-stock index after the insurance giant withdrew its full-year outlook and announced the surprise exit of Chief Executive Officer (CEO) Andrew Witty after four years in the role. The withdrawal of the 2025 outlook comes less than a month after the company slashed its 2025 guidance, saying costs rose as Medicare Advantage care activity had increased at twice the expected rate. Nvidia Corp rallied +5.63% and climbed back above the US$3 trillion level in market capitalisation terms for the first time since February, buoyed by a Bloomberg report that President Trump is planning to unveil a deal that would afford Saudi Arabia more access to advanced chips manufactured by the company and the likes of Advanced Micro Devices (AMD) Inc (+4.01%). To deal with the U.S.'s national security concerns, the U.S. and Saudi governments have reportedly discussed creating data embassies, where data centres will fall under foreign regulations rather than local laws around data protection. Meanwhile, Nvidia Chief Executive Jensen Huang announced a deal to deploy 18,000 chips with newly launched Saudi AI firm Humain for a data centre that is expected to reach 500 megawatts. AMD also announced a US$10B partnership with the artificial intelligence (AI) company to build out its AI infrastructure over the next five years. Boeing Co rose +2.46% following reports that China had lifted its ban on deliveries of US-made aircraft.

Jonny and Richard return to the Morgan Experience Centre in Malvern where, in front of an audience, they discuss peacock damage, extreme roadster face, a strange way of marking time, accidental racist hair, Richard's urge to buy a new podcast car, a new siren for the Eagle, Jonny's weird motorway services rucksack story, highly polished Morgans, stress in a hand car wash, waving at strangers, looking cool on a zero steer mower, the suaveness championship, mayonnaise car care, Grenadier face and Hanley Swan. For early, ad-free episodes and extra content go to patreon.com/smithandsniff To buy merch and tickets to live podcast recordings go to smithandsniff.com  Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

US equity markets soared and settled near their session highs, with the three (3) benchmark indices logging their best single session performance since 9 April after the United States and China said they had agreed to a deal to cut reciprocal tariffs - Dow rose +1,161-points or +2.81% to 42,410.10, its highest close since 26 March and closing 12.66% above its 8 April closing low (37,645.59) to exit a technical correction. Eight of the 30 index components rallied over >5%, including Nike Inc (+7.34%).

Isaac Morgans breaks down the theology of worship at the start of our new talk series : WORSHIP

A relatively muted end to the week for US equity markets following two-days of gains as investors braced for news from highly anticipated trade talks that are scheduled for this weekend in Switzerland between U.S. and Chinese officials - Dow eased -119-points or -0.29% U.S. Treasury Secretary Scott Bessent said “substantial progress” had been made in the weekend trade negotiations between US and China trade officials, adding that the Trump administration “will be giving details tomorrow, but I can tell you that the talks were productive.” In the same statement, U.S. Trade Representative Jamieson Greer agreed that it was “a very constructive two days. It's important to understand how quickly we were able to come to agreement, which reflects that perhaps the differences were not so large as maybe thought.” China's delegation later described the weekend meetings as “candid, in-depth and constructive dialogue,” and said a joint statement would be issued Monday (12 May). No specific details of possible points of agreement were revealed by either side. On Friday (9 May), Trump floated the idea of bringing down China's tariff rate to 80%.

US equity markets advanced but settled well off their session highs, with investor sentiment buoyed a new trade agreement forged between the United States and Britain, while President Trump indicated upcoming talks with China would be “very substantive” and, if productive, could lead to tariff reductions - Dow rose +254-points or +0.62% to 41,368.48, just failing to exit official correction territory. Boeing Co rallied +3.31% and was the leading performer in the 30-stock index after U.S. Commerce Secretary Howard Lutnick said the UK would buy US$10B of aircraft from the aerospace company. Walt Disney Co +2.97% a day after the entertainment giant posted a stronger-than-expected adjusted earnings per share (EPS) and revenue and unveiled a plan to build a theme park in Abu Dhabi, United Arab Emirates.

US equity markets advanced after a choppy session as investors digested the latest corporate earnings releases and the Federal Reserve's monetary policy decision and soundbites from President Trump on tariffs and trade restrictions - Dow rose +285-points or +0.70%. Nvidia Corp (+3.10%) and the broader chip sector got a boost late in the session after Bloomberg reported that the Trump administration plans to rescind Biden-era AI chip curbs as part of a broader effort to revise semiconductor trade restrictions.

US equity markets retreated as investors digested a fresh slew of earnings reports and ahead of the Federal Reserve's latest interest rate decision tomorrow morning AEST - Dow fell -390-points or -0.95% Merck & Co -4.59% was the worst performer in the 30-stock index, while Amgen Inc (-3.43%) and UnitedHealth Group Inc (-2.54%) fell over >2.5%

This episode we discuss the league in CHCH, Morgans run, Mandy pies, Tim Dillon re posts, Twin peaks all over, Corde roading, Aussie flora and fauna, Crusher Collins, NZDF, Joels mysterious lights, Bread n Circus and much more. Enjoy. Support The Joel and Tim Show on Patreon: https://www.patreon.com/user?u=74670148 Support us with caffeinated beverages at https://www.buymeacoffee.com/thejoelandv

US equity markets advanced - Dow eased -99-points or -0.24%, paring an earlier decline of over >250-points. Microsoft Corp (up +0.2%) extended the gap over Apple Inc (down -3.15%) as the largest company in the U.S. by market capitalisation

US equity markets advanced to cap as investors reacted to strong monthly employment data and news that China is evaluating the possibility of trade talks with the U.S. - Dow rose +564-points or +1.39% to 41,317.43. American Express Co (up +3.09%), 3M Co (+3.03%) and Nike Inc (+3.22%) all climbed over >3%. Nvidia Corp rose +2.59% a report in The Information that the artificial intelligence (AI) chipmaker is working to design semiconductors to sell in China that would comply with U.S. trade restrictions. Microsoft Corp rallied +2.32%, lifting its market capitalisation to ~US$3.235 trillion and pushed passed Apple Inc (down 3.74%, market capitalisation ~US$3.067 trillion) to become the largest company in the U.S. by market capitalisation as investors responded to the latest quarterly results from the technology giants last week. Apple CEO Tim Cook said Trump administration tariffs could cost the iPhone maker US$900M this quarter. Meanwhile, Microsoft closes Skype tonight AEST, the pioneering video-calling service it acquired for US$8.5B 14 years ago.

US equity markets made a positive start to May, with the Dow and S&P 500 extending their rally into an eighth consecutive session amid fresh gains for megacap technology stocks - Dow added +84-points or +0.21% Microsoft Corp +7.63% was the leading performer in the 30-stock index the technology giant reported better-than-expected third-quarter financials after the close of the previous session amid soaring cloud demand. Nvidia Corp rose +2.47% investors welcomed the news that Microsoft and Meta Platforms Inc expect to continue investing heavily in artificial intelligence (AI) infrastructure

• A late rally lifted the Dow and S&P 500 into positive territory for a seventh consecutive session to cap a very volatile month, erasing earlier declines that followed data recording that the US economy contracted for the first time in three years in the first quarter - Dow rose +142-points or +0.35%, recovering from an earlier slide of more than >780-points. Verizon Communications Inc (up +2.58%) and Chevron Corp (down -2.33%) were the best and worst performers respectively in the 30-stock index overnight

The Dow and S&P 500 extended their rally into a sixth consecutive session after Commerce Secretary Howard Lutnick said the Trump administration has negotiated its first trade deal with an unnamed country - Dow rose +300-points or +0.75%, logging its longest winning streak since the period ended 17 July, 2024. Amazon.com Inc slipped -0.17%, recovering from an earlier decline of more than >2%, after White House Press Secretary Karoline Leavitt called the company's reported plan to highlight the impact of tariffs in its pricing a "hostile and political act." Amazon later said such a plan "was never approved and is not going to happen."

The Dow and S&P 500 posted a fifth consecutive session of gains, booking their longest winning streak of 2025 to date and settling well off their session lows in a muted trading to open a very busy week of corporate earnings and economic data - Dow rose +114-points or +0.28%. Boeing Co rose +2.44% to US$182.30, buoyed by an upgrade from analysts at Bernstein to ‘outperform with a target price of US$218 (from US$181 previously), and as its deal to reacquire Spirit AeroSystems Holdings (+2.61%) cleared another hurdle. International Business Machines (IBM) Corp +1.61% after pledging a US$150B investment over the next five years to aid the development of technology in the U.S. The company said it would invest more than US$30B in research and development to continue its domestic manufacturing of mainframe and quantum computers. Nvidia Corp fell -2.05% following a Wall Street Journal (WSJ) report that China's Huawei Technologies has developed a new chip called the Ascend 910D, with hopes it will become be more powerful than Nvidia's H100. Huawei is already poised to ship more than 800,000 of its Ascend 910B and 910C chips to customers including state-owned telecommunications carriers and private AI developers, such as TikTok's parent ByteDance, according to the WSJ. Nvidia's H100 was released in 2022 and has since been superseded by later generations of its Hopper chips and its new Blackwell AI semiconductors. Nvidia is prohibited from selling its most powerful AI chips to Chinese companies.

US equity markets extended their strong rebound into a fourth consecutive session on Friday (25 April), lifting the S&P and Nasdaq to their highest settlements since 2 April (the day the Trump administration unveiled sweeping tariffs on America's trading partners) – Dow edged +20-points or +0.05% higher after climbing +487-points or +1.23% last Thursday (24 April). Nvidia Corp (up +4.30%) was the leading performer in the 30-stock index. Merck & Co Inc rose +3.63% a day after the pharmaceutical major delivered better-than-expected first-quarter financial result, with EPS of US$2.22 (versus consensus US$2.13) and revenue of US$15.5B (versus consensus US$15.4B) topping consensus analysts forecasts. The pharmaceutical major slightly lowered its earnings forecast for 2025 to account for a US$200M upfront payment to Hengrui Pharma in a licensing deal, now projecting non-GAAP EPS of between US$8.82 and US$8.97 (down from a range of between US$8.88 and US$9.03 previously).

US equity markets advanced, consolidating the strong gains recorded in the previous session and lifting the S&P 500 and Nasdaq to their highest settlements since 15 April as investors continued to cheer a cooling President's rhetoric around tariffs and his criticism of Federal Reserve Chair Jerome Powell- Dow rose +420-points or +1.07% to 39,606.57, paring an earlier rally of as much as 1,189-points that lifted the index to 40,376.11. Amazon.com Inc (up +4.28%) and Nvidia Corp (+3.86%) both gained ~4%.

US equity markets rebounded strongly, more than recouping the previous session's sharp declines as investors digested a busy corporate earnings calendar and comments from Treasury Secretary Scott Bessent - Dow rose +1,017-points or +2.66%, with all 30 index components advancing. Nvidia Corp +2.04% after Amazon.com Inc (+3.50%) pushed back against reports that it was pulling back on building artificial-intelligence (AI) infrastructure. “This is routine capacity management, and there haven't been any recent fundamental changes in our expansion plans,” wrote Kevin Miller, vice president of global data centres (DC) at Amazon Web Services (AWS), in a post on LinkedIn late Monday (21 April) in response to reports that the Cloud business delayed several new DC leases. Boeing Co rose +2.00% after the aerospace company agreed to sell portions of its Digital Aviation Solutions business to private-equity firm Thoma Bravo in a deal worth US$10.55B.

US equity markets resumed trading following the Good Friday holiday with steep losses, with the so-called ‘Magnificent Seven' cohort of large capitalisation technology stocks under particular pressure - Dow shed -972-points or -2.48%, extending its decline into a fourth consecutive session. UnitedHealth Group Inc (down -6.34%) was the worst performing Dow component overnight, extending the health insurer's two-day decline to -27.3% - the stock's worst two-day performance since 7 August, 1998 – after releasing its first quarter result last Thursday (17 April) and lowering its annual profit forecast on expectations of high medical costs for the rest of the year. Nvidia Corp lost -4.51% after Reuters reported that Huawei Technologies planned to begin mass shipments of an advanced artificial intelligence (AI) chip to customers in China as early as next month. Meanwhile, Chief Executive Officer (CEO) Jensen Huang met Japanese Prime Minister Shigeru Ishiba on Monday (21 April), following a meeting with Chinese leaders in Beijing last Thursday (17 April). Nike Inc (up +0.65%) was the only Dow component to advance overnight.

US equity markets tumbled as investors digested news of U.S. restrictions on chip exports to China and Federal Reserve Chair Jerome Powell's latest assessment of the economy - Dow dropped -700 or -1.73% Nvidia Corp -6.87% after disclosing in a filing with the Securities and Exchange Commission (SEC) after the close of the previous session that sales of its H20 chips to China would require licenses from the Department of Commerce “for the indefinite future”. The chipmaker said it would record charges in its fiscal first quarter of up to US$5.5B for inventory and cancelled sales.

US equity markets retreated in muted trading - Dow fell -156-points or -0.38% Boeing Co fell -2.36% and was the worst performer in the 30-stock index after a Bloomberg report said China ordered its airlines not to take any further deliveries of the company's jets, marking the latest escalation in the trade war between Washington and Beijing.

US equity markets advanced after another choppy session following another flurry of tariff-related headlines, but settled well off their session highs - Dow rose +312-points or +0.78% to 40,524.79. Apple Inc rose +2.21%, paring an earlier gain of as much as +7.5% after the US administration that some consumer electronics and computer hardware would be exempt from the reciprocal 125% trade tariffs placed on China. Nvidia Corp (down -0.20%) said it would for the first time make artificial-intelligence (AI) supercomputers entirely in the United States. Nvidia said it expects to produce up to US$500B in AI infrastructure in the U.S. with its partners within the next four years.

US equity markets advanced as investors digested another busy slate of information including the latest developments in a trade war with China, earnings reports from major banks and economic data - Dow rose +619-points or +1.56%, with the 30-stock index trading in an 1,150 point range after swinging more than >2,000 points between its high and low for the day in each of the preceding four (4) trading sessions. Apple Inc (up +4.06%) was the leading Dow component on Friday (11 April) amid growing optimism the iPhone maker could win an exemption from the Trump administration's tariffs. Nvidia Corp, which outsources manufacturing to Taiwan Semiconductor Manufacturing Company (TSMC) Ltd (up +3.94% on the New York Stock Exchange), gained +3.12% after the China Semiconductor Industry Association said chips made by U.S. firms with outsourced manufacturing operations would not be subject to tariffs on U.S. goods. Meta Platforms Inc (up +7.7%) and the Federal Trade Commission face off tonight AEST over antitrust allegations which could force the social media giant to unwind its acquisition of messaging platform WhatsApp and photo-sharing app Instagram. Chief Executive Officer (CEO) Mark Zuckerberg is expected to appear in the witness stand.

US equity markets retreated, handing back a portion of the huge gains logged in the previous session's near record breaking rebound. Losses accelerated after the White House confirmed that the cumulative tariff rate on China would actually total 145% (consisting of the new 125% duty on goods, on top of the 20% rate levied in response to the fentanyl crisis), overshadowing cooler-than-expected inflation figures.

Wrapping up a series of 5 episodes, Dr Jarvis finishes his discussion of mechanical CPR devices (MCDs) talking about papers from Utah, Vienna, Anchorage, and Cincinnati and then gives his take on how to interpret the literature and put it into practice.Papers discussed:1)    Youngquist ST, Ockerse P, Hartsell S, Stratford C, Taillac P: Mechanical chest compression devices are associated with poor neurological survival in a statewide registry: A propensity score analysis. Resuscitation. 2016;September;106:102–7.2)    Zeiner S, Sulzgruber P, Datler P, Keferböck M, Poppe M, Lobmeyr E, Van Tulder R, Zajicek A, Buchinger A, Polz K, et al.: Mechanical chest compression does not seem to improve outcome after out-of hospital cardiac arrest. A single center observational trial. Resuscitation. 2015;November;96:220–5.3)    Levy M, Yost D, Walker RG, Scheunemann E, Mendive SR: A quality improvement initiative to optimize use of a mechanical chest compression device within a high-performance CPR approach to out-of-hospital cardiac arrest resuscitation. Resuscitation. 2015;July;92:32–7.4)    Morgan S, Gray JJ, Sams W, Uhl K, Gundrum M, McMullan J: LUCAS Device Use Associated with Prolonged Pauses during Application and Long Chest Compression Intervals. Prehospital Emergency Care. 2023;March 9;28(1):114–7.5)    Grunau B, Reynolds J, Scheuermeyer F, Stenstom R, Stub D, Pennington S, Cheskes S, Ramanathan K, Christenson J: Relationship between Time-to-ROSC and Survival in Out-of-hospital Cardiac Arrest ECPR Candidates: When is the Best Time to Consider Transport to Hospital? Prehospital Emergency Care. 2016;September 2;20(5):615–22.  FAST25 | May 19-21, 2025 | Lexington, KY

We work out where you do your best thinking, play a round of year of the song and the team give Ducko their suggestions for Morgans push playlist!Subscribe on LiSTNR: https://play.listnr.com/podcast/nick-jess-and-duckoSee omnystudio.com/listener for privacy information.

Should Ducko change the style of his face snake, we get Morgans reactions to the teams song selections for her birthing playlist and Jess wants to know if she's overreacting after something Angus said to her last night!Subscribe on LiSTNR: https://play.listnr.com/podcast/nick-jess-and-duckoSee omnystudio.com/listener for privacy information.

Is there a similarity between F1 driver Oscar Piastri and our very own Shy Guy? We find out if your relationship started with fast food and Morgans tasked Ducko in creating a push playlist and we need your help!Subscribe on LiSTNR: https://play.listnr.com/podcast/nick-jess-and-duckoSee omnystudio.com/listener for privacy information.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WQG865. CME/MOC/AAPA/IPCE credit will be available until March 14, 2026.Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WQG865. CME/MOC/AAPA/IPCE credit will be available until March 14, 2026.Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WQG865. CME/MOC/AAPA/IPCE credit will be available until March 14, 2026.Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WQG865. CME/MOC/AAPA/IPCE credit will be available until March 14, 2026.Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WQG865. CME/MOC/AAPA/IPCE credit will be available until March 14, 2026.Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WQG865. CME/MOC/AAPA/IPCE credit will be available until March 14, 2026.Individualizing Prostate Cancer Management: Employing Evidence-Based Strategies to Impact Community Care Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

Hi Guys, welcome back to TV Reload. Thank you for clicking or downloading on today’s episode with Alana McClean… who is basically now a Real Housewife of Beverely Hills herself after receiving a like on social media from Dorit this week. We go deep on the 14th episodes of Beverely Hills season 14 which are called Hemlines and headlines and this could be the most different reaction Alana and I have had of the season and we will get into that. Plus guys if you want to score the eps too? Please hit us up on social media. We will discuss, the way in which Garcelle and Sutton have double standards… and maybe that happens when you have been on a show like this for as long as they have been. I will get Alana’s perspective on Morgans name coming up a fair bit and what she thinks at this stage. Has this relationship been an emotional affair or was this at one stage actually romantic. We will address the fact Sutton’s Mum couldn’t make the fashion show and why Sutton wouldn’t just pop her on a private plane. You are going to get plenty of chat on Dorit’s catch up with Garcelle. What we think of the modelling career trajectory of children of these housewives and of source we will unpack that tweet from Alana that Dorit popped a like on.. There is so much to talk about with so many inside revelations. So sit back and relax as we unpack the wonderful world of the RHOBH season 14!See omnystudio.com/listener for privacy information.

With the Australian reporting season just about coming to an end, Nvidia has been a big focus for investors on Wall Street. MARKET WRAP: ASX200: up 0.33%, 8,268 GOLD: $2,909 US/oz BITCOIN: $136,955 AUD Qantas shares jumped another 5.6% on the day to $9.39 – and has gained more than 80% over the last year. Medibank Private announced better retention of clients and fewer claims shares up just under 10% to $4.42 Ramsay Health Care shares up more than 6% to $36.18 Infratil lifted more than 2% to $9.72 after an increase in shareholding from some board members. Sequoia reported 137% lift in profit - shares jumped more than 3% to 44 ½ cents. Perpetual fell just under 10% after a disappointing reporting result and again confirming the takeover from private equity firm KKR was off the table. Mercury New Zealand shares down 7% to $5.40 Pro medicus fell more than 3% to $263.08 and CSL fell 1.7% to $260.29 And Wisetech global have had a busy week, but shares were sold down today down to $93.99. CURRENCY UPDATE: AUD/USD: 62.95 US cents AUD/GBP: 49.7 pence AUD/EUR: 60 Euro cents AUD/JPY: 94 Japanese yen AUD/NZD: 1.10 NZ dollars See omnystudio.com/listener for privacy information.

For our month of romcoms, we revisit a late era Hugh Grant flick in which he pairs up with Sarah Jessica Parker.  Basically what City Slickers would be like if you replaced Billy Crystal with Hugh Grant and both Daniel Stern and Bruno Kirby with Sarah Jessica Parker.  And Jack Palance with Sam Elliott, which is probably the nearest to a 1 to 1 ratio.

Both the Australian sharemarket and dollar were hit hard after the US confirmed import tariffs will be applied on Mexican, Canadian and Chinese products from Feburary 4th, so SBS Finance Editor Ricardo Gonçalves takes a closer look at the implications for the sharemarket and for Australia with Raymond Chan from Morgans; Rhayna Bosch speaks with Tim Lawless from CoreLogic on the year ahead in property.

Get ready for one of the most inspiring episodes yet with the legendary lad Morgan Mitchell. Born deaf, Morgan's journey to becoming a professional rugby player was never going to be easy. Although he was an absolute beast on the rugby field from a young age, he was always told that he would never be able to play professional rugby. Thankfully the man who is known for his stubbornness was not having a bar of it and did manage to debut for his beloved Southland stags in 2014. He has since gone on to play over 50 games for the Stags as well as playing overseas with the Toronto ArrowsKamaishi Seawaves and Houston SaberCats.This story is a great one about never giving up on your dreams and a great reminder of some of the obstacles you can overcome when you put your mind to it. Morgy is such a champion, a very funny man and like his brother Brayden can tell a hell of a yarn. It was an honour to be the first podcast to share Morgans journey and if you enjoy this episode then I ask if you could please like the video and let me know what you enjoyed about this one in the comments.EXCLUSIVE NordVPN Deal ➼ https://nordvpn.com/whatalad Try it risk-free now with a 30-day money-back guarantee Hosted on Acast. See acast.com/privacy for more information.

It's a brave new world Dear Listeners. Your usual trio of numpties Andy, Ant and Dun guide you through the last week in QPR, New York, Executive orders and the New World Order. Thank god for the football... - We're Ninth! We're in Single digits! (until tomorrow) - 2 away games, 6 points, a ton of miles - The Contract kids, Lloyd and Kolli make the away fans Jolly - Why is Plymouth's keeper so bloody good against us - A great week for the Morgans, Keiran & Fox - A varied week for our Loanees. Edwards looks a steal, Ashby a sub-par sub - Koki's not hokey - Saito's stunning first goal for the club - We're 9th! Single digits! - A 'this week in New Yorking' x 'Democracy Manifest' Mash-up - The Gulf of America, America America and Johnny Childish - NFL stuff. New York happy: Buffalo advance to take on the Chiefs. New Jersey not happy: Saquon lifts the Eagles to an NFC East match up vs The Commanders - Dun doesn't do buses, even if they're quicker - Andy's a scale-model citizen - Ant's low blood pressure TV guide - Seann Walsh visits the Football Factory: Stand-up comedian and a stand-up guy - A gritty tale from Scunthorpe - Sheffield Wednesday up next. Will QPR have an 'owler? - QPR NYC's favorite New York Bands do South x South West London. - 'Fix your hearts or die' - RIP David Lynch. Thank you for the damn fine Cherry Pie. If you feel so inclined, hit us up with that sweet sweet 5 star review! All feedback most welcome.

Dr. Susan Fay is an internationally-known speaker, clinician, consultant, and author of Sacred Spaces -Communion with the horse through Science and Spirit. She has an educational background in psychology, and environmental science, but believes she learned the most valuable life lessons from her horses. Susan acquired numerous local, national, and world championships on her beloved Morgans, but retired from the show ring to devote her time to teaching. Her passion is to introduce people to psychological and energetic principles that allow them to BE in this world in a more meaningful way, and to experience communion with their horses, dogs, and other animals.

We know the literature on mechanical CPR devices on mortality in out of hospital cardiac arrest (we DO know this literature, right?), but what about in-hospital arrest? Dr. Jarvis reviews a recent paper that uses the AHA Get With The Guidelines - Resuscitation registry to assess the association between MCDs and mortality. Citations1. Crowley C, Salciccioli J, Wang W, Tamura T, Kim EY, Moskowitz A: The association between mechanical CPR and outcomes from in-hospital cardiac arrest: An observational cohort study. Resuscitation. 2024;May 1;198.2. Rubertsson S, Lindgren E, Smekal D, Östlund O, Silfverstolpe J, Lichtveld RA, Boomars R, Ahlstedt B, Skoog G, Kastberg R, et al.: Mechanical Chest Compressions and Simultaneous Defibrillation vs Conventional Cardiopulmonary Resuscitation in Out-of-Hospital Cardiac Arrest: The LINC Randomized Trial. JAMA. 2014;January 1;311(1):53–613. Hardig BM, Lindgren E, Östlund O, Herlitz J, Karlsten R, Rubertsson S: Outcome among VF/VT patients in the LINC (LUCAS IN cardiac arrest) trial—A randomised, controlled trial. Resuscitation. 2017;June;115:155–62.4.  Perkins GD, Lall R, Quinn T, Deakin CD, Cooke MW, Horton J, Lamb SE, Slowther A-M, Woollard M, Carson A, et al.: Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial. The Lancet. 2015;385(9972):947–55.5.  Wik L, Olsen J-A, Persse D, Sterz F, Lozano M, Brouwer MA, Westfall M, Souders CM, Malzer R, Van Grunsven PM, et al.: Manual vs. integrated automatic load-distributing band CPR with equal survival after out of hospital cardiac arrest. The randomized CIRC trial. Resuscitation. 2014;June;85(6):741–8.6. Bonnes JL, Brouwer MA, Navarese EP, Verhaert DVM, Verheugt FWA, Smeets JLRM, Boer M-J de: Manual Cardiopulmonary Resuscitation Versus CPR Including a Mechanical Chest Compression Device in Out-of-Hospital Cardiac Arrest: A Comprehensive Meta-analysis From Randomized and Observational Studies. Ann Emerg Med Annals of emergency medicine. 2016;67(3):349-360.e3.7. Gonzales L, Oyler BK, Hayes JL, Escott ME, Cabanas JG, Hinchey PR, Brown LH: Out-of-hospital cardiac arrest outcomes with “pit crew” resuscitation and scripted initiation of mechanical CPR. The American Journal of Emergency Medicine. 2019;May;37(5):913–20.8. Koster RW, Beenen LF, Van Der Boom EB, Spijkerboer AM, Tepaske R, Van Der Wal AC, Beesems SG, Tijssen JG: Safety of mechanical chest compression devices AutoPulse and LUCAS in cardiac arrest: a randomized clinical trial for non-inferiority. European Heart Journal. 2017;October 21;38(40):3006–13.9. Primi R, Bendotti S, Currao A, Sechi GM, Marconi G, Pamploni G, Panni G, Sgotti D, Zorzi E, Cazzaniga M, et al.: Use of Mechanical Chest Compression for Resuscitation in Out-Of-Hospital Cardiac Arrest—Device Matters: A Propensity-Score-Based Match Analysis. JCM. 2023;June 30;12(13):4429.10. Youngquist ST, Ockerse P, Hartsell S, Stratford C, Taillac P: Mechanical chest compression devices are associated with poor neurological survival in a statewide registry: A propensity score analysis. Resuscitation. 2016;September;106:102–7.11.  S, Sulzgruber P, Datler P, Keferböck M, Poppe M, Lobmeyr E, Van Tulder R, Zajicek A, Buchinger A, Polz K, et al.: Mechanical chest compression does not seem to improve outcome after out-of hospital cardiac arrest. A single center observational trial. Resuscitation. 2015;November;96:220–5. 12. Morgan S, Gray JJ, Sams W, Uhl K, Gundrum M, McMullan J: LUCAS Device Use Associated with Prolonged Pauses during Application and Long Chest Compression Intervals. Prehospital Emergency Care. doi: 10.1080/10903127.2023.2183294 (Epub ahead of print).13.  Levy M, Yost D, Walker RG, Scheunemann E, Mendive SR: A quality improvement initiative to optimize use of a mechanical chest compression device within a high-performance CPR approach to out-of-hospital cardiac arrest resuscitation. Resuscitation. 2015;July;92:32–7.14.  Li H, Wang D, Yu Y, Zhao X, Jing X: Mechanical versus manual chest compressions for cardiac arrest: a systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2016;December;24(1):10.15.  Sheraton M, Columbus J, Surani S, Chopra R, Kashyap R: Effectiveness of Mechanical Chest Compression Devices over Manual Cardiopulmonary Resuscitation: A Systematic Review with Meta-analysis and Trial Sequential Analysis. WestJEM. 2021;July 19;22(4):810–9.16.  Wang PL, Brooks SC: Mechanical versus manual chest compressions for cardiac arrest. Cochrane Database Syst Rev The Cochrane database of systematic reviews. 2018;20;8:CD007260.17.  Zhu N, Chen Q, Jiang Z, Liao F, Kou B, Tang H, Zhou M: A meta-analysis of the resuscitative effects of mechanical and manual chest compression in out-of-hospital cardiac arrest patients. Crit Care. 2019;December;23(1):100.